Related Experiment Video

Updated: Aug 13, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

The global impact of vaccines containing aluminium adjuvants

C J Clements1, E Griffiths

  • 1Expanded Programme on Immunization, Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization, Geneva, Switzerland. clem@who.int

Vaccine
|August 20, 2002
PubMed

Insights

Aluminium adjuvants are crucial for vaccine effectiveness in childhood immunization programs like the Expanded Programme on Immunization (EPI). Future vaccines will likely require new adjuvants, highlighting their continued importance.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Childhood immunization is a cornerstone public health intervention.
  • Aluminum-based adjuvants have been integral to vaccines in the Expanded Programme on Immunization (EPI).
  • The global supply of Diphtheria, Tetanus, and Pertussis (DTP) vaccines is vulnerable.

Purpose of the Study:

  • To discuss the impact and essential role of adjuvants in vaccines.
  • To explore the limitations of non-aluminium adjuvants as replacements.
  • To consider the future need for novel adjuvants in new vaccine generations.

Main Methods:

  • Literature review on vaccine adjuvants.
  • Analysis of the historical impact of aluminium adjuvants.
  • Discussion on the future of adjuvant technology in vaccinology.

Main Results:

  • Aluminium adjuvants have reliably enhanced vaccine efficacy for decades.
  • Non-aluminium adjuvants are not immediate replacements for current aluminium-based formulations.
  • The development of new-generation adjuvants is anticipated for future vaccines.

Conclusions:

  • Adjuvants, particularly aluminium-based ones, are vital for effective immunization.
  • The long-term use and evolution of adjuvants in vaccines are expected.
  • Continued research into novel adjuvants is necessary for advancing vaccine technology.

More Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses06:02

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...